Unlock regulatory insights with Watson. Learn More

Requests That the FDA Withdraw its Draft Guidance and Refrain from Taking any Action Affecting Personal Sound Amplification Products and Cease Further Efforts to Expand the Scope of the Generic Device Known as a Hearing Aid.

Docket Item Code P
Center CDRH
VIEW ALL (4)Primary Documents